Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Johnson and Johnson
Express Scripts
Medtronic
Mallinckrodt

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RISPERIDONE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Risperidone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000267 Risperidone Treatment in Dually-Diagnosed Individuals - 2 Completed New York State Psychiatric Institute Phase 2 1969-12-31 The purpose of this study is to evaluate the safety and efficacy of risperidone for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
NCT00000267 Risperidone Treatment in Dually-Diagnosed Individuals - 2 Completed National Institute on Drug Abuse (NIDA) Phase 2 1969-12-31 The purpose of this study is to evaluate the safety and efficacy of risperidone for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
NCT00000272 New Approaches to Cocaine Abuse Medications (B) - 7 Completed New York State Psychiatric Institute Phase 2 1995-03-01 The purpose of this study is to measure the effect of risperidone in cocaine abusers.
NCT00000272 New Approaches to Cocaine Abuse Medications (B) - 7 Completed National Institute on Drug Abuse (NIDA) Phase 2 1995-03-01 The purpose of this study is to measure the effect of risperidone in cocaine abusers.
NCT00000309 Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 Terminated National Institute on Drug Abuse (NIDA) Phase 2 1994-08-01 The purpose of this study is to evaluate use of risperidone with cocaine abusers. Study measures incorporate an appropriate integration of behavioral and neurobiological indices.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Risperidone

Condition Name

Condition Name for Risperidone
Intervention Trials
Schizophrenia 281
Schizoaffective Disorder 61
Bipolar Disorder 45
Psychotic Disorders 40
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Risperidone
Intervention Trials
Schizophrenia 302
Psychotic Disorders 119
Disease 105
Mental Disorders 68
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Risperidone

Trials by Country

Trials by Country for Risperidone
Location Trials
United States 972
China 52
Canada 47
Spain 40
Italy 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Risperidone
Location Trials
California 87
New York 75
Texas 56
Ohio 51
Florida 48
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Risperidone

Clinical Trial Phase

Clinical Trial Phase for Risperidone
Clinical Trial Phase Trials
Phase 4 176
Phase 3 121
Phase 2/Phase 3 7
[disabled in preview] 73
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Risperidone
Clinical Trial Phase Trials
Completed 340
Terminated 41
Unknown status 36
[disabled in preview] 45
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Risperidone

Sponsor Name

Sponsor Name for Risperidone
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Janssen, LP 38
National Institute of Mental Health (NIMH) 35
[disabled in preview] 29
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Risperidone
Sponsor Trials
Other 437
Industry 324
NIH 55
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Dow
Mallinckrodt
Boehringer Ingelheim
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.